Rabdosia rubescens (Hemsl.) H. Hara: A potent anti-tumor herbal remedy - Botany, phytochemistry, and clinical applications and insights
- PMID: 39631716
- DOI: 10.1016/j.jep.2024.119200
Rabdosia rubescens (Hemsl.) H. Hara: A potent anti-tumor herbal remedy - Botany, phytochemistry, and clinical applications and insights
Abstract
Ethnopharmacological relevance: Traditional Chinese herbal medicine has unique advantages as anti-cancer drugs and adjuvant therapies. Rabdosia rubescens (Hemsl.) H. Hara (R. rubescens) is a traditional medicinal plant known for its anti-inflammatory, antioxidant, antibacterial, anti-angiogenic and antitumor properties. The antitumor activity of R. rubescens is widely recognized among the folk communities in Henan Province, China.
Aim of the study: This study reviews the botany, ethnopharmacology, phytochemistry, anti-tumor active ingredients, mechanisms, and clinical applications of R. rubescens, aiming to provide a comprehensive understanding for its use as an anti-cancer drug and adjuvant therapy.
Materials and methods: We systematically searched the literature in PubMed, Web of Science, and CNKI using the following keywords: "Rabdosia rubescens", "Isodon rubescens", "traditional application", "anti-tumor", "phytochemistry", "anti-tumor active compounds", "oridonin" and "clinical application". The search covered publications from 1997 to 2024. Inclusion criteria included original studies or reviews focusing on the anti-tumor properties of R. rubescens or its active components. Exclusion criteria included studies related to non-R. rubescens applications.
Results: R. rubescens is a perennial herbaceous plant in the family Lamiaceae, mainly found in central and southern China. Historically, it has been used to treat conditions such as sore throat, cough, and excess phlegm. The plant contains various compounds, including diterpenes, triterpenes, steroids, flavonoids, phenolic acids, essential oils, amino acids, alkaloids, and polysaccharides, with diterpenes, triterpenes, flavonoids, and phenolic acids being the most active. This review identifies 50 compounds with anti-tumor properties, comprising 34 diterpenes, 2 triterpenes, 7 flavonoids, and 7 phenolic acids. Notably, besides oridonin and ponicidin, the ent-kaurane diterpenoids (20S)-11β,14β,20-trihydroxy-7α,20-epoxy-ent-kaur-16-en15-one and (20S)-11β,14β-dihydroxy-20-ethoxy7α,20-epoxy-ent-kaur-16-en-15-one demonstrate significant anti-tumor activity, attributed to their carbonyl group at C-15, hydroxyl group at C-1, and OEt group at C-20. Mechanistically, R. rubescens combats tumors by blocking the tumor cell cycle, promoting apoptosis, inhibiting cell migration and angiogenesis, inducing ferroptosis, reversing drug resistance, and enhancing radiosensitivity in tumor cells. Clinically, R. rubescens is available in various forms, including tablets, drops, syrups, capsules, and lozenges, and is primarily used for tonsillitis, pharyngitis, and stomatitis. According to the 2020 edition of the Pharmacopoeia of China, R. rubescens tablets are recognized as an adjuvant therapy for cancer. Clinical studies indicate that R. rubescens syrup, tablets, and thermal therapy can enhance cancer patient survival rates and lower tumor recurrence rates.
Conclusions: Given its traditional and modern uses, active anti-tumor components, and mechanisms, R. rubescens is a promising resource in traditional Chinese medicine for anti-tumor therapy. To realize its full potential, future research should explore additional active anti-tumor compounds beyond oridonin and ponicidin. For these key components, studies should focus on structural modifications to identify new active molecules and essential anti-tumor structures. Clinically, it is important to investigate how R. rubescens interacts with other Chinese herbs in anti-tumor formulations to enhance treatment efficacy and guide appropriate clinical use. Furthermore, future studies should undergo ethical review and include larger-scale randomized controlled trials to validate the efficacy of R. rubescens in treating tumors, thereby promoting its role as an anti-tumor traditional Chinese medicine.
Keywords: Anti-tumor activity; Botany; Clinical applications; Ethnopharmacology; Phytochemistry; Rabdosia rubescens (Hemsl.) H. Hara.
Copyright © 2024 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors have declared that no competing interest exists.
Similar articles
-
Violae Herba: A comprehensive review of the traditional uses, phytochemistry, pharmacology, quality control and clinical applications.J Ethnopharmacol. 2025 Jul 24;351:119561. doi: 10.1016/j.jep.2025.119561. Epub 2025 Apr 4. J Ethnopharmacol. 2025. PMID: 40188895 Review.
-
Longan Arillus: A comprehensive review of botany, traditional uses, phytochemistry, pharmacologic activities, pharmacokinetics, quality control, toxicity, and clinical applications.J Ethnopharmacol. 2025 Jul 24;351:120131. doi: 10.1016/j.jep.2025.120131. Epub 2025 Jun 10. J Ethnopharmacol. 2025. PMID: 40505758 Review.
-
Abrus cantoniensis Hance: Ethnopharmacology, phytochemistry and pharmacology of a promising traditional Chinese medicine.J Ethnopharmacol. 2024 Nov 15;334:118543. doi: 10.1016/j.jep.2024.118543. Epub 2024 Jul 8. J Ethnopharmacol. 2024. PMID: 38986752
-
Botany, traditional uses, phytochemistry, pharmacology, edible uses, and quality control of Lablab semen Album: A systematic review.J Ethnopharmacol. 2024 Nov 15;334:118507. doi: 10.1016/j.jep.2024.118507. Epub 2024 Jun 28. J Ethnopharmacol. 2024. PMID: 38945467
-
Botany, traditional usages, phytochemistry, pharmaceutical analysis, and pharmacology of Eleutherococcus nodiflorus (Dunn) S.Y.Hu: A systematic review.J Ethnopharmacol. 2023 Apr 24;306:116152. doi: 10.1016/j.jep.2023.116152. Epub 2023 Jan 11. J Ethnopharmacol. 2023. PMID: 36641105
Cited by
-
Integrated miRNAome, transcriptome, and degradome analyses reveal the role of miRNA-mRNA modules in the biosynthesis of oridonin in Isodon rubescens.Front Plant Sci. 2025 Jun 18;16:1566354. doi: 10.3389/fpls.2025.1566354. eCollection 2025. Front Plant Sci. 2025. PMID: 40606481 Free PMC article.
-
Paxilline derived from an endophytic fungus of Baphicacanthus cusia alleviates hepatocellular carcinoma through autophagy-mediated apoptosis.Sci Rep. 2025 May 27;15(1):18464. doi: 10.1038/s41598-025-03044-1. Sci Rep. 2025. PMID: 40425675 Free PMC article.
-
Identification of novel potential biomarkers using bulk RNA and single cells to build a neural network model for diagnosis of liver cancer.Discov Oncol. 2025 May 12;16(1):728. doi: 10.1007/s12672-025-02420-7. Discov Oncol. 2025. PMID: 40353917 Free PMC article.
-
Ursolic acid induces apoptosis in nasopharyngeal carcinoma cells through the P53 signaling pathway: a network pharmacology and experimental validation study.Med Oncol. 2025 May 1;42(6):189. doi: 10.1007/s12032-025-02749-7. Med Oncol. 2025. PMID: 40310511
-
LncRNA LUCAT1 as a prognostic biomarker in cholangiocarcinoma through targeting miR-141-3p: clinical and functional insights.Hereditas. 2025 Jul 26;162(1):143. doi: 10.1186/s41065-025-00512-6. Hereditas. 2025. PMID: 40713875 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous